Azithromycin for community treatment of suspected COVID-19 in people at increased risk of an adverse clinical course in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial

収録刊行物

  • The Lancet

    The Lancet 397 (10279), 1063-1074, 2021-03

    Elsevier BV

被引用文献 (1)*注記

もっと見る

問題の指摘

ページトップへ